ArchPoint Investors’s Astria Therapeutics ATXS Stock Holding History

ArchPoint Investors’s Portfolio ATXS Stock Details ATXS Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell
2022 Q3	$220K	Sell
2022 Q2	$77K	Hold
2022 Q1	$173K	Hold
2021 Q4	$139K	Sell
2021 Q3	$250K	Buy
2021 Q2	$352K	Buy
2021 Q1	$471K	Buy